Literature DB >> 10873618

Dual anticancer activity of 8-Cl-cAMP: inhibition of cell proliferation and induction of apoptotic cell death.

S N Kim1, S G Kim, J H Park, M A Lee, S D Park, Y S Cho-Chung, S H Hong.   

Abstract

8-Cl-cAMP induces apoptotic cell death in human cancer cells. To look at this more closely, we examined the changes in the levels of Bcl-2 family proteins during 8-Cl-cAMP-induced apoptosis of SH-SY5Y human neuroblastoma cells. Following the treatment with 8-Cl-cAMP, Bcl-2 was transiently down-regulated and Bad was increased continuously up to day 5. In addition, overexpression of Bcl-2 efficiently blocked the 8-Cl-cAMP-induced apoptosis, suggesting Bcl-2 family proteins may be involved in the 8-Cl-cAMP-induced apoptosis. The contribution of the apoptotic cell death and the inhibition of cell proliferation in the 8-Cl-cAMP-induced growth inhibition was closely monitored in the Bcl-2-overexpressing cells. Though the apoptosis was reduced significantly, no significant difference was observed in the inhibition of cell proliferation up to day 2 of 8-Cl-cAMP treatment. These results suggest that 8-Cl-cAMP exerts anticancer activity by two distinct mechanisms, i.e. , through the inhibition of cell proliferation as well as the induction of apoptosis. Supporting this notion was the observations that (1) suppression of apoptosis by zVAD did not abrogate 8-Cl-cAMP-induced inhibition of cell proliferation, and (2) 8-Cl-cAMP did not show additive inhibition of cell proliferation in RIIbeta-overexpressing cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873618     DOI: 10.1006/bbrc.2000.2949

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  The combination of sulfinosine and 8-Cl-cAMP induces synergistic cell growth inhibition of the human neuroblastoma cell line in vitro.

Authors:  Dragana Janković; Milica Pesić; Jasna Marković; Selma Kanazir; Ivanka Marković; Ljubisav Rakić; Sabera Ruzdijić
Journal:  Invest New Drugs       Date:  2006-01       Impact factor: 3.850

2.  Effect of theophylline and specific phosphodiesterase IV inhibition on proliferation and apoptosis of progenitor cells in bronchial asthma.

Authors:  Chun-Hua Wang; Horng-Chyuan Lin; Chien-Huang Lin; Chih-Teng Yu; Su-Ling Liu; Kuo-Hsiung Huang; Kian Fan Chung; Han-Pin Kuo
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

3.  The cAMP analogs have potent anti-proliferative effects on medullary thyroid cancer cell lines.

Authors:  Alessandra Dicitore; Elisa Stellaria Grassi; Michele Caraglia; Maria Orietta Borghi; Germano Gaudenzi; Leo J Hofland; Luca Persani; Giovanni Vitale
Journal:  Endocrine       Date:  2015-04-12       Impact factor: 3.633

4.  In vitro and in vivo inhibition of SK-N-MC neuroblastoma growth using cyclic nucleotide phosphodiesterase inhibitors.

Authors:  M Giorgi; C Leonetti; G Citro; G Augusti-Tocco
Journal:  J Neurooncol       Date:  2001-01       Impact factor: 4.130

5.  A study on the genotoxic effects of 8-Cl-cAMP on human lymphocytes in vitro.

Authors:  V Bajić; N Djelić; B Spremo-Potparević; L Zivković; Z Milićević
Journal:  Genetika       Date:  2008-05

6.  E2F1-mediated DNA damage is implicated in 8-Cl-adenosine-induced chromosome missegregation and apoptosis in human lung cancer H1299 cells.

Authors:  Yu-Ying Han; Zhe Zhou; Ji-Xiang Cao; Ya-Qiong Jin; Shu-Yan Li; Ju-Hua Ni; Guo-Shun An; Yu-Xiang Zhang; Hong-Ti Jia
Journal:  Mol Cell Biochem       Date:  2013-09-15       Impact factor: 3.396

7.  Hybridization Properties of RNA Containing 8-Methoxyguanosine and 8-Benzyloxyguanosine.

Authors:  Daniel Sylwester Baranowski; Weronika Kotkowiak; Ryszard Kierzek; Anna Pasternak
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

8.  8-Cl-Adenosine enhances 1,25-dihydroxyvitamin D3-induced growth inhibition without affecting 1,25-dihydroxyvitamin D3-stimulated differentiation of primary mouse epidermal keratinocytes.

Authors:  Wendy B Bollag; Xiaofeng Zhong; Sarah Josephson
Journal:  BMC Pharmacol       Date:  2004-07-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.